A new study reveals how the immune system behaves in people who have had complications from surgical mesh implants.

Result? There is evidence of ongoing, abnormal immune activation throughout the body, not just at the implant site.

Most research on mesh complications looks at local problems such as damage or inflammation where the mesh is placed. However, this paper asks a bigger question. Do these patients also have a whole‑body (systemic) immune response, not just a local one?

The answer appears to be YES.

The study was conducted by a team at the NHS Newcastle Mesh Complication Centre who say the mechanisms underpinning mesh complications remain largely unknown. Also, there are no reports characterising systemic immune dysregulation – in other words, the immune system not working as it should.

The team studied patients who were having bladder mesh slings removed. They analysed immune-related proteins in their blood by testing how immune cells behaved when exposed to mesh material.

They found that:

• Patients with mesh complications had higher levels of certain immune/chemical signals
• Their immune cells also produced inflammatory molecules

Conclusion

• People with mesh complications may have a distinct altered immune system response
• In future, doctors might:
  • identify biomarkers (via blood tests)
  • predict who is at risk
  • monitor reactions better

Why it matters

• Mesh complications are not just “mechanical” problems
• They may involve systemic (whole-body) immune and inflammatory responses
• This could change how clinicians:
  • assess patients before surgery
  • understand complications
  • make treatment decisions

---

Summary

The paper shows that people with mesh complications have measurable changes in their immune system throughout the body, suggesting complications may be partly driven by systemic inflammation not just local damage.

Title: Systemic immune dysregulation in patients experiencing urogynaecological mesh failure

“There is growing concern pertaining to the systemic effects of urogynaecological implants highlighted through patient reports and increased media attention.”